phenethyl isothiocyanate has been researched along with Bladder Cancer in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 7 (63.64) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Blaheta, RA; Chun, FK; Cinatl, J; Grein, T; Haferkamp, A; Khadir, SE; Makhatelashvili, N; Mann, J; Maxeiner, S; Rutz, J; Sonnenburg, M; Thomas, A; Tsaur, I; Xie, H | 1 |
| Li, LM; Lin, Y; Tang, K | 1 |
| Fujioka, M; Gi, M; Hirayama, Y; Kakehashi, A; Kato, M; Koyama, Y; Nakatani, T; Tachibana, H; Tamada, S; Wanibuchi, H; Yamano, S | 1 |
| Asamoto, M; Hirose, M; Ogawa, K; Shirai, T; Sugiura, S; Takeshita, F | 1 |
| Hampton, MB; King, MJ; Midwinter, RG; Pullar, JM; Thomson, SJ; Turnbull, CI | 1 |
| Hirose, M; Inoue, K; Kato, N; Lee, KY; Shibutani, M; Takagi, H; Uneyama, C | 1 |
| Li, J; Yao, S; Zhang, Y | 2 |
| Li, G; Song, L; Tang, L; Zhang, Y | 1 |
| Futakuchi, M; Hirose, M; Kimoto, N; Ogawa, K; Sano, M; Shirai, T; Yamaguchi, T | 1 |
| Cui, L; Hirose, M; Imaida, K; Ogawa, K; Ogiso, T; Shirai, T; Sugiura, S | 1 |
11 other study(ies) available for phenethyl isothiocyanate and Bladder Cancer
| Article | Year |
|---|---|
Allyl-, Butyl- and Phenylethyl-Isothiocyanate Modulate Akt-mTOR and Cyclin-CDK Signaling in Gemcitabine- and Cisplatin-Resistant Bladder Cancer Cell Lines.
Topics: Apoptosis; Carcinoma, Transitional Cell; Cell Line, Tumor; Cisplatin; Cyclin-Dependent Kinases; Cyclins; Deoxycytidine; Gemcitabine; Humans; Isothiocyanates; Proto-Oncogene Proteins c-akt; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases; Urinary Bladder Neoplasms | 2022 |
The role of phenethyl isothiocyanate on bladder cancer ADM resistance reversal and its molecular mechanism.
Topics: Anticarcinogenic Agents; Apoptosis; Carcinoma; Cell Line, Tumor; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Isothiocyanates; Rhodamine 123; Signal Transduction; Urinary Bladder Neoplasms | 2013 |
Carbonic anhydrase 2 is a novel invasion-associated factor in urinary bladder cancers.
Topics: Adult; Aged; Aged, 80 and over; Animals; Animals, Genetically Modified; Carbonic Anhydrase II; Carcinogens; Disease Models, Animal; Female; Genes, ras; Humans; Isothiocyanates; Male; Middle Aged; Neoplasm Invasiveness; Nitrosamines; Proto-Oncogene Mas; Proto-Oncogene Proteins p21(ras); Rats; Urinary Bladder; Urinary Bladder Neoplasms | 2017 |
Reversibility of proliferative lesions and induction of non-papillary tumors in rat urinary bladder treated with phenylethyl isothiocyanate.
Topics: Animals; Base Sequence; Carcinogens; Cell Division; DNA Primers; Isothiocyanates; Male; Rats; Rats, Inbred F344; Urinary Bladder; Urinary Bladder Neoplasms | 2003 |
The chemopreventive agent phenethyl isothiocyanate sensitizes cells to Fas-mediated apoptosis.
Topics: Aldehyde Dehydrogenase; Anticarcinogenic Agents; Apoptosis; Buthionine Sulfoximine; Caspase 3; Caspases; Chemoprevention; Drug Resistance, Neoplasm; fas Receptor; Humans; Isothiocyanates; JNK Mitogen-Activated Protein Kinases; Jurkat Cells; MAP Kinase Kinase 4; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Urinary Bladder Neoplasms | 2004 |
Limited tumor-initiating activity of phenylethyl isothiocyanate by promotion with sodium L-ascorbate in a rat two-stage urinary bladder carcinogenesis model.
Topics: Animals; Ascorbic Acid; Body Weight; Carcinoma; Diet; Hyperplasia; Isothiocyanates; Male; Rats; Rats, Inbred F344; Urinary Bladder Neoplasms | 2005 |
The role of c-Jun in the AP-1 activation induced by naturally occurring isothiocyanates.
Topics: Anticarcinogenic Agents; Biotransformation; Blotting, Western; Carcinogens; Cell Line, Tumor; DNA, Neoplasm; Electrophoretic Mobility Shift Assay; Gene Expression Regulation, Neoplastic; Genes, fos; Genes, jun; Humans; Isothiocyanates; Luciferases; Phosphorylation; Transcription Factor AP-1; Urinary Bladder Neoplasms | 2005 |
The principal urinary metabolites of dietary isothiocyanates, N-acetylcysteine conjugates, elicit the same anti-proliferative response as their parent compounds in human bladder cancer cells.
Topics: Acetylcysteine; Apoptosis; Cell Cycle; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Isothiocyanates; Sulfoxides; Thiocyanates; Urinary Bladder Neoplasms | 2006 |
c-jun/AP-1 activation does not affect the antiproliferative activity of phenethyl isothiocyanate, a cruciferous vegetable-derived cancer chemopreventive agent.
Topics: Anticarcinogenic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Humans; Isothiocyanates; JNK Mitogen-Activated Protein Kinases; Peptide Fragments; Proto-Oncogene Proteins c-jun; Replication Protein C; Signal Transduction; Transcription Factor AP-1; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 2006 |
Strong promoting activity of phenylethyl isothiocyanate and benzyl isothiocyanate on urinary bladder carcinogenesis in F344 male rats.
Topics: Animals; Butylhydroxybutylnitrosamine; Carcinogens; Diet; Diethylnitrosamine; Drug Synergism; Hyperplasia; Isothiocyanates; Liver; Male; Rats; Rats, Inbred F344; Urinary Bladder; Urinary Bladder Neoplasms | 1998 |
Dose-dependent promotion by phenylethyl isothiocyanate, a known chemopreventer, of two-stage rat urinary bladder and liver carcinogenesis.
Topics: Animals; Anticarcinogenic Agents; Body Weight; Carcinogens; Diet; Dose-Response Relationship, Drug; Drug Stability; Hyperplasia; Isothiocyanates; Liver Neoplasms; Male; Organ Size; Rats; Rats, Inbred F344; Urinary Bladder Neoplasms | 2001 |